ReviewCancers2023
Synovial Sarcoma in the Extremity: Diversity of Imaging Features for Diagnosis and Prognosis.
Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 31 citations in OpenAlex.
- Diagnostic challenges in synovial sarcoma: a case report.Journal of medical case reports · 2026Article
- Apatinib inhibits synovial sarcoma progression and angiogenesis via VEGFR2-mediated AKT/FOXO3A and ERK1/2/FOXM1 signaling pathways.Cell death discovery · 2026Article
- Monophasic synovial sarcoma of the thigh in a 60-year-old patient: A rare case report and literature review.Radiology case reports · 2026Article
- Multifocal tenosynovial giant cell tumor: A case report.Radiology case reports · 2026Article
- Soft Tissue Masses of the Hand.Seminars in musculoskeletal radiology · 2025Review
- Review
- Biphasic Synovial Sarcoma of the Palatine Tonsil: A Case Report and Literature Review.Clinical case reports · 2025Article
- The role of molecular pathology in soft tissue tumor diagnosis: what the radiologist needs to know.Skeletal radiology · 2025Review
- Synovial sarcoma mimicking infrapatellar bursitis: A diagnostic challenge.Radiology case reports · 2025Article
- Synovial Sarcoma: Malignant Soft Tissue Sarcoma With Benign Clinical Characteristics-A Case Report.Case reports in pathology · 2025Article
- A 40-year-old female with swelling in left lower back.Skeletal radiology · 2025Article
- Unusual manifestation of synovial sarcoma: A rare case report with elevated beta HCG level.Radiology case reports · 2024Article
- Painless knee mass in a young adult: answer.Skeletal radiology · 2024Article
- [Importance and implementation of radiological modalities in the diagnostics of soft tissue tumors].Radiologie (Heidelberg, Germany) · 2024Article
- Tonsillar synovial sarcoma, unusual anatomical location: case report and literature review.Diagnostic pathology · 2024Review
- Diffuse-Type Tenosynovial Giant Cell Tumor: What Are the Important Findings on the Initial and Follow-Up MRI?Cancers · 2024Review
- Case report: Characteristics and nature of primary cardiac synovial sarcoma.Frontiers in oncology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
Synovial sarcomas are rare and highly aggressive soft-tissue sarcomas, primarily affecting adolescents and young adults aged 15-40 years. These tumors typically arise in the deep soft tissues, often near the large joints of the extremities. While the radiological features of these tumors are not definitely indicative, the presence of calcification in a soft-tissue mass (occurring in 30% of cases), adjacent to a joint, strongly suggests the diagnosis. Cross-sectional imaging characteristics play a crucial role in diagnosing synovial sarcomas. They often reveal significant characteristics such as multilobulation and pronounced heterogeneity (forming the "triple sign"), in addition to features like hemorrhage and fluid-fluid levels with septa (resulting in the "bowl of grapes" appearance). Nevertheless, the existence of non-aggressive features, such as gradual growth (with an average time to diagnosis of 2-4 years) and small size (initially measuring < 5 cm) with well-defined margins, can lead to an initial misclassification as a benign lesion. Larger size, older age, and higher tumor grade have been established as adverse predictive indicators for both local disease recurrence and the occurrence of metastasis. Recently, the prognostic importance of CT and MRI characteristics for synovial sarcomas was elucidated. These include factors like the absence of calcification, the presence of cystic components, hemorrhage, the bowl of grape sign, the triple sign, and intercompartmental extension. Wide surgical excision remains the established approach for definitive treatment. Gaining insight into and identifying the diverse range of presentations of synovial sarcomas, which correlate with the prognosis, might be helpful in achieving the optimal patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.